Tertiary lymphoid structures in esophageal cancer: a novel target for immunotherapy
Frontiers in Immunology · 2025
DOI: 10.3389/fimmu.2025.1543322 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2025. Verfasst von Ke Zhai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Tertiary Lymphoid Structures, Immunotherapy, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Esophageal cancer (EC), especially esophageal squamous cell carcinoma (ESCC), which is the most common subtype in China, is one of the most aggressive gastrointestinal malignancies. Traditional treatments like surgery, radiotherapy, and chemotherapy have limited success, but the study of tertiary lymphoid structure (TLS) has opened new avenues for immunotherapy. TLS is an ectopic immune cell cluster, including B cells, T cells, and dendritic cells (DCs), that forms in chronic inflammation such as tumors. TLS is often found at tumor invasion margins and is linked to better prognosis in EC patients, with higher TLS density and maturation associated with prolonged survival. TLS can also serve as a biomarker to assess immunotherapy outcomes. Further exploration of TLS molecular mechanisms could innovate EC treatments, especially by inducing TLS formation to improve therapy. This review summarizes the characteristics of TLS in EC, clinical findings, and the limitations and directions of current research, offering insights for future immunotherapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Zitieren
APA
Zhai, K., Ma, Y., Gao, X., Ru, K., & Zhao, M. (2025). Tertiary lymphoid structures in esophageal cancer: a novel target for immunotherapy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1543322
Vancouver
Zhai K, Ma Y, Gao X, Ru K, Zhao M. Tertiary lymphoid structures in esophageal cancer: a novel target for immunotherapy. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1543322
BibTeX
@article{Zhai2025,
author = {Zhai, Ke and Ma, Yuting and Gao, Xue and Ru, Kun and Zhao, Miaoqing},
title = {Tertiary lymphoid structures in esophageal cancer: a novel target for immunotherapy},
journal = {Frontiers in Immunology},
year = {2025},
doi = {10.3389/fimmu.2025.1543322}
}
EUVIMED